Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentationMaja Šolman, Daniel Abankwa|eLife|2015Cited by 50
SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and SignalingElina Siljamäki, Daniel Abankwa|Molecular and Cellular Biology|2016Cited by 25
Rapalogs can promote cancer cell stemness <i>in vitro</i> in a Galectin-1 and H-ras-dependent mannerItziar M. D. Posada, Daniel Abankwa|Oncotarget|2017Cited by 23
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit <i>KRAS</i> Mutant Cancer Cell GrowthPelin Kaya, Daniel Abankwa|Journal of Medicinal Chemistry|2024Cited by 23
Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cellsGanesh babu Manoharan, Daniel Abankwa|PLoS ONE|2022Cited by 18